Atlas Trials

CHOlesterol Lowering and Residual Risk in Type 2 Diabetes

Clinical trial NCT04369664 · COMPLETED

Trial details

NCT number
NCT04369664
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2020-08-12
Primary completion
2023-09-25
Enrollment
151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.